Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394. Little-known Novellus is licensing the drug,...
1.
Liu, G. L. et al. A nanoplasmonic molecular ruler for measuring nuclease activity and DNA footprinting. Nat. Nanotechnol. 1, 47–52 (2006).
2.
Nguyen, A. W....
Artificial Intelligence (AI) is broadly expanding in the market. Several AI startups and Artificial intelligence initiatives exist in the market.
In this digital era,...
Many conditions and treatments can weaken a person’s immune system (making them “immunocompromised”). Some of these include:
Cancer
Bone marrow transplant
Solid organ transplant
Stem cells for...
The scientific community, after conducting several prominent studies and reviews, agrees unanimously that lawmakers need to revisit the legal status ...
Feb 06, 2020
(Nanowerk Spotlight) Small magnetic objects, which have been used successfully in technological applications such as data storage, also show promise...
